130 related articles for article (PubMed ID: 28551623)
1. The Immunological Roles of Periostin/Tumor-Associated Macrophage Axis in Development of Dermatofibrosarcoma Protuberans.
Fujimura T; Kakizaki A; Sato Y; Tanita K; Furudate S; Aiba S
Anticancer Res; 2017 Jun; 37(6):2867-2873. PubMed ID: 28551623
[TBL] [Abstract][Full Text] [Related]
2. A possible interaction between periostin and CD163
Fujimura T; Kakizaki A; Furudate S; Aiba S
Exp Dermatol; 2017 Dec; 26(12):1193-1198. PubMed ID: 27501402
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression.
Sasaki M; Ishida T; Horiuchi H; MacHinami R
Pathol Int; 1999 Sep; 49(9):799-806. PubMed ID: 10504551
[TBL] [Abstract][Full Text] [Related]
4. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
Kubo M; Ihn H; Yamane K; Tamaki K
Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
[TBL] [Abstract][Full Text] [Related]
5. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
Mori T; Misago N; Yamamoto O; Toda S; Narisawa Y
J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of matrix metalloproteinases 1, 2, 9, and 14 in dermatofibrosarcoma protuberans and common fibrous histiocytoma (dermatofibroma).
Weinrach DM; Wang KL; Wiley EL; Laskin WB
Arch Pathol Lab Med; 2004 Oct; 128(10):1136-41. PubMed ID: 15387709
[TBL] [Abstract][Full Text] [Related]
7. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
Sachdev R; Sundram U
J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa.
Cohen PR; Rapin RP; Farhood AI
Am J Dermatopathol; 1994 Oct; 16(5):573-4. PubMed ID: 7528477
[No Abstract] [Full Text] [Related]
10. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
11. CD206
Haque ASMR; Moriyama M; Kubota K; Ishiguro N; Sakamoto M; Chinju A; Mochizuki K; Sakamoto T; Kaneko N; Munemura R; Maehara T; Tanaka A; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2019 Oct; 9(1):14611. PubMed ID: 31601953
[TBL] [Abstract][Full Text] [Related]
12. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
[TBL] [Abstract][Full Text] [Related]
13. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
14. [Differences of the molecular phenotypes and the histogenesis between dermatofibroma and dermatofibrosarcoma protuberans].
Xiong Y; Guo H; Zhang S; Zhang B; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):395-400. PubMed ID: 18677387
[TBL] [Abstract][Full Text] [Related]
15. The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides.
Furudate S; Fujimura T; Kakizaki A; Kambayashi Y; Asano M; Watabe A; Aiba S
Exp Dermatol; 2016 Feb; 25(2):107-12. PubMed ID: 26441016
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-27 is expressed in CD163+/CD206+ M2 macrophages in the cycling human endometrium and in superficial endometriotic lesions.
Cominelli A; Gaide Chevronnay HP; Lemoine P; Courtoy PJ; Marbaix E; Henriet P
Mol Hum Reprod; 2014 Aug; 20(8):767-75. PubMed ID: 24810263
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of platelet-derived growth factor and its receptors in fibrohistiocytic tumors.
Taniuchi K; Yamada Y; Nonomura A; Takehara K
J Cutan Pathol; 1997 Aug; 24(7):393-7. PubMed ID: 9274955
[TBL] [Abstract][Full Text] [Related]
18. [Fibrosarcomatous dermatofibrosarcoma protuberans: a clinicopathological analysis of 12 cases].
Zhang J; Wu N; Xia C; Wei X; Shi QL; Zhou XJ; Ma J
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):753-7. PubMed ID: 24447553
[TBL] [Abstract][Full Text] [Related]
19. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
[TBL] [Abstract][Full Text] [Related]
20. IGFBP7, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.
Li J; Yu Y; Yang Y; Wang L; Cao J; Liang X; Xiao X; Tu Y; Chen H
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):382-5. PubMed ID: 21492256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
